Shore ND, De Giorgi U, Tutrone RF, Bailen JL, et al. Enzalutamide Monotherapy for the Treatment of Prostate Cancer With High-Risk Biochemical Recurrence: EMBARK Secondary Endpoints. J Urol 2025 Dec 5:101097JU0000000000004879. doi: 10.1097/JU.0000000000004879.
PMID: 41349040